Chagas disease

Happy to announce the agreement between Mundo Sano Foundation and World Health Oganization

8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole in the early stages of infection can cure the Chagas disease, but currently very few people are able to […]

By |November 9th, 2017|Institutional News|0 Comments

WHO and Mundo Sano Foundation to facilitate access to paediatric treatment of Chagas disease

8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole in the early stages of infection can cure the Chagas disease, but currently very few people are able to […]

By |November 9th, 2017|Media impacts|0 Comments

A New Strategy to Undermine Big Pharma’s Price Gouging Actually Worked

Last week, the Food and Drug Administration announced its approval of the drug benznidazole, which is used to treat a parasitic disease that afflicts about 300,000 Americans and that, left untreated, can lead to heart failure. It sounds like a routine case of government agencies doing routine work—a relief during the Trump administration. For once, […]

By |September 8th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 7th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 7th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 7th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 6th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 6th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 6th, 2017|Media impacts|0 Comments

U.S. FDA Approves Chemo Group’s Benznidazole to Treat Children with Chagas Disease

On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an essential medicine for Chagas disease, a dangerous parasitic disease that affects an estimated 6 to 8 million people worldwide. In the United […]

By |September 6th, 2017|Media impacts|0 Comments